跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 59,705 条关于
“MAESTRO-NAFLD-1”
全部
59,705
临床试验
35,881
药物
7,248
机构
1,397
资讯
15,179
去年
Madrigal's Rezdiffra Shows Promise in MASH Cirrhosis with Two-Year Data
2年前
Madrigal's Resmetirom Nears Full Approval for NASH Cirrhosis Treatment Following Phase 3 Enrollment Completion
去年
Resmetirom Shows Promise in Treating MASLD/MASH: A Comprehensive Review of Clinical Trials
去年
Madrigal Pharmaceuticals Initiates FDA Submission for NASH Treatment Resmetirom
3个月前
Rezdiffra Demonstrates Cardiovascular and Liver Risk Reduction in MASH Patients
去年
Liver Cirrhosis Pipeline Shows Strong Growth with 30+ Therapies in Development Across Multiple Clinical Phases
9个月前
Liver Cirrhosis Pipeline Shows Strong Growth with 30+ Companies Advancing Novel Therapies Through Clinical Trials
去年
Madrigal's Resmetirom Shows Promise in NASH Treatment Where Others Have Failed
去年
FDA Approves Rezdiffra (resmetirom) for NASH with Liver Fibrosis
去年
Moon Surgical Secures FDA Clearance for AI-Powered ScoPilot on Maestro System
第 1 页,共 1518 页
上一页
下一页